
U.S. Opens Trade Investigation Into Germany's Pharmaceutical Pricing Policies
Washington has launched a formal Section 301 probe targeting Germany's drug reimbursement system, warning the policies unfairly burden American pharmaceutical companies and could trigger punitive tariffs on German imports.






